This inventor holds 25 USPTO granted patents and 8 published patent applications, plus 2 CIPO patents and 5 EPO patents, primarily in Immunotherapy Research. Top assignees: Heat Biologics, Inc., Pelican Therapeutics, Inc., University of Miami. Active years: 2016-2024.
Location History:
- Raleigh, NC (US) (2018)
- North Bay Village, FL (US) (2016 - 2021)
- Miami, FL (US) (2017 - 2021)
- Durham, NC (US) (2018 - 2023)
Company Filing History:
15 out of 15 
4 out of 4 
4 out of 391 
Years Active: 2016-2024
Areas of Expertise:
Title: The Innovative Contributions of Taylor H. Schreiber in Biomedicine
Introduction
Taylor H. Schreiber, located in Raleigh, NC, is a prominent inventor known for his significant contributions to the field of biomedicine. With an impressive portfolio of 20 patents, Schreiber has been at the forefront of developing innovative solutions and therapies aimed at combating various diseases, particularly in the realms of cancer treatment and immunotherapy.
Latest Patents
Among Schreiber's latest inventions are two notable patents that showcase his groundbreaking work. The first patent, titled "Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins," involves the creation of chimeric proteins designed to treat diseases, particularly through immunotherapies for cancer and autoimmunity. This invention presents a range of embodiments that include fusions of extracellular domains of transmembrane proteins, potentially yielding both stimulatory and inhibitory effects in therapeutic applications.
The second patent titled "Intratumoral vaccination" details a method for treating tumors by delivering an effective amount of a composition through intratumoral injection. This composition contains an expression vector encoding a secretable vaccine protein along with a T cell costimulatory fusion protein, advancing the approach towards more effective cancer treatments.
Career Highlights
Throughout his career, Taylor H. Schreiber has collaborated with leading organizations in the biotechnology sector, such as Heat Biologics, Inc. and Pelican Therapeutics, Inc. His work in these companies has allowed him to push the boundaries of cancer immunotherapy and develop novel treatments that address critical medical challenges.
Collaborations
In his professional journey, Schreiber has partnered with notable colleagues, including George Fromm and Suresh De Silva. These collaborations have fostered an environment of innovation and creativity, enabling the exploration of new methodologies and the advancement of therapeutic techniques.
Conclusion
In conclusion, Taylor H. Schreiber's contributions to biomedicine significantly impact the landscape of disease treatment, particularly in the field of cancer therapies. With his extensive portfolio of patents and collaborative spirit, Schreiber continues to influence the future of medical science, paving the way for novel therapeutic approaches that hold promise for improving patient outcomes.